Role of Two-Component System Response Regulators in Virulence of Streptococcus pneumoniae TIGR4 in Infective Endocarditis by Trinh, My
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
2011
Role of Two-Component System Response
Regulators in Virulence of Streptococcus
pneumoniae TIGR4 in Infective Endocarditis
My Trinh
Virginia Commonwealth University
Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Medicine and Health Sciences Commons
© The Author
This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses
and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/etd/2374
© My N. Trinh, 2011
All Rights Reserved
ROLE OF TWO-COMPONENT SYSTEM RESPONSE REGULATORS IN
VIRULENCE OF STREPTOCOCCUS PNEUMONIAE TIGR4 IN INFECTIVE
ENDOCARDITIS
A thesis submitted in fulfillment of the requirements for the
degree of Master of Science at Virginia Commonwealth University
By
MY N. TRINH
B.A., University of Virginia, 2009
Director: PING XU, Ph.D.
Associate Professor of Oral & Craniofacial Molecular Biology and
Microbiology & Immunology
Virginia Commonwealth University
Richmond, Virginia
May 2011
ii
ACKNOWLEDGEMENT
I would like to express the utmost appreciation and sincerest thank you to
my mentor, Dr. Ping Xu, for taking me into his lab, giving me so much of his time
and teaching and believing in me.  It is to him that I owe my success at Virginia
Commonwealth University and in much of my future endeavors.  I would also like
to thank my fellow lab members and colleagues, especially Xiuchun Ge, Lei
Chen, Jenishkumar Patel, and Nicai Zollar, in the Philips Institute at VCU for their
extremely helpful guidance and patience.  I am grateful for Dr. Todd Kitten and
Dr. Cindy Munro for offering me their valuable time and wisdom by being my
committee members. Last, but not least, I want to acknowledge my friends and
family, especially my mom, for their endless support, which gives me confidence
in everything I do.
iii
TABLE OF CONTENTS
Page
List of Tables………………………………………………………….…..…….…..……v
List of Figures…………………………………………………….….……..…….…..…vi
List of Abbreviations...…….………………….………………….…….……….……....vii
Abstract……………...………………………………………………………...……...…ix
I.  Introduction…………………………………………………………………...………1
Infective Endocarditis…………………………………………………….……...1
Streptococcus pneumoniae .…..………………………………………………....2
Two Component Systems……………………………………………….....……3
Specific Aims…..……………………………………………………….…….....3
Significance..………………………………………………………….…......…..4
II. Materials and Methods .……..………………………………………………….…...5
Bacterial strains………………………………………………………………….5
Bacterial cultivation and cell preparation ...………………………..…….…..…8
Construction of mutants ………………………………………………………...8
Purification of PCR amplified fragments……………….……………….….…14
THY+HCl preparation………………………….…………….………………..14
Agar plate preparation………………………………………………………….14
Transformation………...……………………………………………………….15
Mutant confirmation and sequencing……………….………………….………16
In vitro studies……………………………………………………..…………..16
In vivo endocarditis model…………………………………………..…………20
iv
Statistical Analysis……………………………………………………………..21
Blood killing assay………………………………………...…………..……….21
Literature and database search………………………...……………….………22
III. Results………………………………………………………………………....…23
Identification of TCS genes in S. pneumoniae TIGR4 strain……………….…23
Construction of mutants…….…………………………………………...……..26
Confirmation of mutants by colony PCR and sequencing……………….…….26
Establishment of S. pneumoniae TIGR4 cell cultures…….….………………..34
Examination of in vitro studies.………………………....……………………..38
Examination of in vivo studies……………………………...…………………41
Examination of CiaR mutant in endocarditis virulence……………………......44
Blood killing assay………………………………………………….…….……44
IV. Discussion……………………………….…………………………….…………..47
V.  Literature Cited………………………………………………………….………....60
vLIST OF TABLES
Page
Table 1: Bacterial strains used in this study………………………………………...6
Table 2: List of primers used for this study…………………………………....……10
Table 3: List of RR genes used for study…………………………………………..24
Table 4: Sequence data of mutant strains…………………………………………32
Table 5: qPCR results and CI data…….…………………………………..……….42
Table 6: Putative target genes of ciaR……………………………………………..55
vi
LIST OF FIGURES
Page
Figure 1: Schematic of mutant DNA construction and transformation…………..12
Figure 2: 0.1% Agarose gel electrophoresis of mutant DNA PCR products…....28
Figure 3: 0.1% Agarose gel electrophoresis of DNA from colony PCR...……….30
Figure 4: Growth curve of stock TIGR4 cells to mid-log phase……...…………...36
Figure 5: In vitro growth curve of individually inoculated RR mutants………...…39
Figure 6: In vitro and in vivo competitive index experiment with candidate
virulence factor RR ∆SP_0798………………………………………………….……45
vii
LIST OF ABBREVIATIONS
BHI brain heart infusion
CFU colony forming units
CSP competence stimulating peptide
hrs hours
HBSS Hank’s buffered salt solution
HK histidine kinase
HS horse serum
kb kilobase
M molar
min minute
ml milliliter
ng nanogram
nm nanometer
O/D optical density
PCR polymerase chain reaction
qPCR quantitative real-time polymerase chain reaction
rpm rotation per minute
RR response regulator
sec second
TCS two component system
TH Todd-Hewitt
THY Todd-Hewitt + yeast
viii
TSA tryptic soy agar
µg microgram
µl microliter
ix
ABSTRACT
ROLE OF TWO-COMPONENT SYSTEM RESPONSE REGULATORS IN
VIRULENCE OF STREPTOCOCCUS PNEUMONIAE TIGR4 IN INFECTIVE
ENDOCARDITIS
By My N. Trinh, B.A.
A thesis submitted in partial fulfillment of the requirements for the
Degree of Master of Science at Virginia Commonwealth University
Virginia Commonwealth University, 2011
Director: Ping Xu, Ph.D.
Associate Professor of Oral & Craniofacial Molecular Biology and
Microbiology & Immunology
Streptococci resident in the oral cavity have been linked to infective endocarditis
(IE).  While viridans streptococci are commonly studied and associated with IE, less
research has been focused on Streptococcus pneumoniae. Two-component systems
(TCSs), consisting of a histidine kinase (HK) protein and response regulator (RR)
protein, are bacterial signaling systems that may mediate S. pneumoniae TIGR4 strain
virulence in IE.  To test this hypothesis, TCS RR mutants of TIGR4 were examined in
vivo through use of rabbit models.  There were 14 RR proteins identified and 13 RR
mutants synthesized because SP_1227 was found to be essential.  The requirement of
the 13 RRs for S. pneumoniae growth in IE models was assessed by quantifying
mutants after overnight inoculation in IE infected rabbits through use of real time PCR
(qPCR), colony enumeration on antibiotic selection plates, and competitive index
assays.  Real time PCR pinpointed several candidate virulence factors.  Candidate RR
SP_0798 was selected to be further examined.  In the in vivo model, mutant SP_0798
grew significantly less than our control mutant SP_1678, which encodes a hypothetical
xprotein and grew at a comparable rate to wild-type TIGR4 strains.  Literature and
databases identified SP_0798 as the ciaR gene, which has roles in regulating many
diverse cellular functions.  Our data suggests that RR SP_0798 is a virulence factor of
S. pneumoniae TIGR4 strain in IE.  This research may place more emphasis on
virulence factors and lead to novel methods to combat pneumococcal endocarditis.
1INTRODUCTION
Infective Endocarditis
Infective Endocarditis (IE) is an infection of the heart valves or endocardium that
affects 10,000-20,000 people every year.  Lesions of the heart cause a mass of cells to
form vegetation, thereby allowing bacteria in circulation to colonize to further block
blood flow and immune responses.  Complications from IE can lead to congestive heart
failure, aneurysm, or stroke [1].  Various streptococci commonly found in the oral cavity
have been linked to IE, especially in patients with pre-existing endocardial lesions.
Treatment is difficult, often involving hospitalization and surgery, which still has a high
rate of failure with a mortality rate of approximately 25% and can result in future
morbidity [2].  If left untreated, IE will progress and is uniformly fatal.  Antibiotic
prophylaxis is a common preventative method because it was first believed that invasive
dental procedures disrupting mucosal surfaces facilitated streptococci access into the
bloodstream for infection [3]. However, more recently, most cases of IE are shown to
occur in the absence dental manipulation so antibiotic prophylaxis is ineffective [4]. This
has led to speculation on links between natural human oral flora and their role in
disease.  More specifically, studies are performed to identify virulence factors of
streptococci that allow their success in infection of the blood and heart.  Of these
studies, many have been performed on the IE models concerning the virulence of
viridans streptococci such as Streptococcus sanguinis and Streptococcus mutans,
which are responsible for 30-40% of cases, while little has been studied about the
virulence of Streptococcus pneumoniae, which is more rarely the cause of IE. However,
2there are unique characteristics to pneumococcal endocarditis. For example, Austrian
Syndrome is a condition consisting of meningitis, pneumonia, and endocarditis and
most often observed in middle-aged men with pre-existing conditions such as
alcoholism.  This syndrome is caused S. pneumoniae infection with meningitis
symptoms first seen and endocarditis later diagnosed.  Although Austrian Syndrome is
clinically rare, it is highly aggressive and often fatal because endocarditis is recognized
too late [5].
Streptococcus pneumoniae
S. pneumoniae is a gram-positive, alpha-hemolytic strain of oral streptococci.  It
is natively present in the upper respiratory tract of humans, but may be pathogenic
under certain conditions. Upon infection, S. pneumoniae causes many problems in
human health such as pneumonia, bacteremia, otitis media, meningitis, sinusitis,
peritonitis and arthritis. Several strains of S. pneumoniae have been identified based on
the chemical composition of its polysaccharide capsule, virulence factors, and antigens
produced.  The particular TIGR4 strain has a polysaccharide capsule, which prevents
phagocytosis by the host immune system, and can be up to 105 times more virulent
compared to unencapsulated strains such as R6.  Virulence may also be attributed to
the ability of the bacteria to sense conditions differing from the normal and inducing
cellular changes that allow it to thrive and cause disease.
3Two-component systems
Two-component systems (TCSs) are signaling pathways commonly found in
bacteria.  Studies have shown that TCSs in streptococci play an important role in
virulence [6, 7, 8]. They are composed of a membrane bound protein called a histidine
kinase (HK) that senses environmental changes and autophosphorylates its own
histidine residue.  The HK signals to its corresponding cytosolic response regulator (RR)
protein by transferring the phosphate to an aspartate residue.  The RR undergoes a
conformational change and induces a response by regulating gene transcription.  TCSs
have been shown to modulate responses such as osmoregulation, chemotaxis,
sporulation, photosynthesis, and pathogenicity [9].  In disease, TCSs may regulate
expression of virulence factor genes in response to specific environmental situations.
Specific Aims
We are interested in identifying TCS RR genes of S. pneumoniae TIGR4
involved in infective endocarditis (IE) virulence and investigating their gene regulons. To
do so, we constructed mutant DNA of RRs of TCSs with sequence tags by replacing the
target gene with antibiotic resistance cassettes.  We wanted to generate mutant cells by
transforming TIGR4 cells with mutant DNA of the RR genes by homologous
recombination, however, due to its capsule, the TIGR4 strain is difficult to transform at a
reported efficiency of ~0.02% compared to highly transformable strains such as R6 at
~1%.  In an effort to optimize the transformation efficiency of TIGR4, we tested different
conditions outlined in the basic protocol by Bricker et al. [10]. After experimentation on
source of cells, type of media, incubation time, oxygen environment, pH, and donor
4DNA concentration, we modified the protocol slightly to result in the same reported
transformation efficiency, but was more time efficient. We created 13 RR mutants and
found that the RR Spn_1227 was an essential gene because mutant colonies were not
able to form.  We used these mutants for in vitro studies, as well as in vivo studies in
rabbit endocarditis models.  We examined growth patterns of mutants independently by
optical density measurements and mutants when co-inoculated by real-time PCR.
Competitive Index calculations showed statistically significant decreases in quantity of a
particular mutant in vivo endocarditic models identified candidate virulence factors.  We
confirmed candidates in additional animal experiments, as well as analysis in blood
killing assays.
Significance
We hope to identify specific TCS response regulator mutants that affect growth of
S. pneumoniae in the rabbit endocarditis models and that this recognition of regulons
and pathways involved in virulence will put further emphasis on TIGR4 research in IE
and establish new strategies to combat pneumococcal bacteria.
5MATERIALS & METHODS
Bacterial strains
Bacterial strains used in the following experiment are listed in Table 1.
Streptococcus pneumoniae strain TIGR4 is an original isolate from human blood and
was obtained from the American Type Culture Collection (ATCC).  All other S.
pneumoniae mutant strains used were derived from TIGR4.
6Table 1. Bacterial strains for study
7Table 1
Strain Phenotype Source
S. pneumoniae TIGR4 Human blood isolate American Type Culture Collection
SP_0083 Ermr this laboratory study
SP_0156 Ermr this laboratory study
SP_0376 Ermr this laboratory study
SP_0387 Ermr this laboratory study
SP_0526 Ermr this laboratory study
SP_0603 Ermr this laboratory study
SP_0661 Ermr this laboratory study
SP_0798 Ermr this laboratory study
SP_1633 Ermr this laboratory study
SP_2000 Ermr this laboratory study
SP_2082 Ermr this laboratory study
SP_2193 Ermr this laboratory study
SP_2235 Ermr this laboratory study
SP_1678_Erm Ermr this laboratory study
SP_1678_Km Kmr this laboratory study
8Bacterial cultivation and cell preparation
Frozen cells of S. pneumoniae strains were grown in 5ml of liquid medium of
THY+HCl (Todd-Hewitt broth (Difco) infused with 0.5% yeast extract, 0.5% glycine, and
11mM hydrochloric acid) at 37°C under microaerophilic conditions (6% 02, 80% N2, 7%
CO2, 7% H2) for 18 hrs.  These cells were then diluted 100x’s (56l culture + 5.54ml
THY+HCl) in the same medium and incubated at 37°C under microaerophilic conditions
for 6 hrs to reach mid-log phase or O/D600nm = 0.3, as read by a spectrophotometer.
Mid-log phase cultures were stored as stock with sterile glycerol (10% glycerol + 90%
culture) at -80°C.  Mid-log phase stock cultures were used in all subsequent
experiments.
Mutant construction
To study the virulence of TCSs in IE, mutants were made by deleting putative RR
genes of TIGR4.  Through the use of bioinformatics and homology comparisons among
databases of streptococci, putative RR genes were found as well as their predicted
functions.  To construct mutants, three sets of primers (F1/R1, F2/R2, and F3/R3),
shown in Table 2, were designed for use in polymerase chain reaction (PCR)
amplification of TIGR4 genomic DNA.  Primers F1/R1 amplify the fragment upstream of
the target gene, primers F2/R2 amplify the antibiotic (erythromycin or kanamycin)
resistance gene to replace the target gene, and primers F3/R3 amplify the fragment
downstream of the target gene. We used Invitrogen high fidelity Taq DNA polymerase in
our PCR reaction mixture.  The PCR conditions to amplify each fragment were 94oC for
1 min., followed by 30 cycles at 94oC for 30 s, 54 oC for 30 s, 68 oC for 1 min. 30 s, and
9finally 68 o C for 4 min. The 5’ ends of the F2/R2 primers were complimentary to the
upstream and downstream sequences so that the final PCR product produced was
linear recombinant DNA containing all three fragments.  The final linear DNA construct
was used for homologous recombination into the TIGR4 genome as shown in Figure 1.
The upstream and downstream had long flanking sequences that were approximately 1
kb in length so as to ensure accurate homologous recombination for transformation in to
the TIGR4 genome.  Individual fragments were visualized as bands on 1% gel
electrophoresis and purified as described below.  The PCR conditions for ligation were
94oC for 2 min., followed by 30 cycles at 94oC for 30 s, 54 o C for 30 s, 68 o C for 3 min.
30 s, and finally 68 o C for 10 min. This approximately 3 kb linear DNA product was
again visualized by 1% gel electrophoresis, purified, and further PCR amplified using
the F1/R3 primers.  The concentration of the mutant donor DNA product was measured
by NanoDrop technology.
10
Table 2. Primers used for bacterial strains
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Table 2
Primers               Nucleotides sequences (5’to 3’)
SP_0083 F1 CAT GTG ATT CCA TAC GAA CTC TTC
SP_0083 R1 CCT TCT CAC TAT TTA GTC ATC CAA CTC CCA TCT GTC TCT CCT TTG AT
SP_0083 F3 AAA GGA GGA AAA TCA CAT GTC CAA CTA TAA GAT AGA GAA ACC GAG AGG
SP_0083 R3 CAT CGG TCA CAC TGA TTG AAA G
SP_0156 F1 CCA AAA GCA GGT AGT GGA TTT AGT A
SP_0156 R1 CCT TCT CAC TAT TTA GTC ATC CAA CAT ACA TTT TCT CCC TTT CTA CTC A
SP_0156 F3 AAA GGA GGA AAA TCA CAT GTC CAA CTA CCG AAA ACA GGT AGA AAC TAT A
SP_0156 R3 GGT CCA TTT CAT AGA AAT TTT TGC
SP_0376 F1 GAA AGC TAT GAC TTG ATG CAA CAC T
SP_0376 R1 CCT TCT CAC TAT TTA GTC ATC CAA CCC CCA TGG CTG ACC TAC TTA TT
SP_0376 F3 AAA GGA GGA AAA TCA CAT GTC CAA CCG TGG TGT TGG ATA TAC CAT GC
SP_0376 R3 ATA CCA TTT GCC TCG TACT ATA TTT C
SP_0387 F1 TCT TTT TAT TGT TGG TTT TCA GCA T
SP_0387 R1 CCT TCT CAC TAT TTA GTC ATC CAA CTT TCA TCT TTA CTC CTT TAT CAT TCC
SP_0387 F3 AAA GGA GGA AAA TCA CAT GTC CAA CCA CCA TTT GGT GGG GCA AGA GG
SP_0387 R3 CCC TCC ATT ATC ACA TAA ACA GGT A
SP_0526 F1 ATG AGA AGA CTG GAA GTC TGG TAA A
SP_0526 R1 CCT TCT CAC TAT TTA GTC ATC CAA CTC TCA TCT TCT TAC TCT CCC TC
SP_0526 F3 AAA GGA GGA AAA TCA CAT GTC CAA CGT GTC TGA GGC CAT CAA TAA AT
SP_0526 R3 TAT CTG CTC CAT ATC CTC CTC TTC
SP_0603 F1 GCT CTT GAG CAA TCT ATC TCT GGT A
SP_0603 R1 CCT TCT CAC TAT TTA GTC ATC CAA CTT TCA TAC TTT AAC TGC TCT CTA TTT
SP_0603 F3 AAA GGA GGA AAA TCA CAT GTC CAA CCG CAA TGT TGG TTA TAA ATT GGA G
SP_0603 R3 AAA GTA TCT GCA GAA CAT GGT GAT T
SP_0661 F1 AGG AAA ACT TGA AGA ATT TTG TGG T
SP_0661 R1 CCT TCT CAC TAT TTA GTC ATC CAA CGG TCA TGC TCT GCT CCT TTA CC
SP_0661 F3 AAA GGA GGA AAA TCA CAT GTC CAA CCC TCG TCA GTT TAA GAA GGG AG
SP_0661 R3 ACA GAC AAG AAG AGA TGT GAC ACT G
SP_0798 F1 GTT GCT AAA TTG GCT CGT CAT AAC T
SP_0798 R1 CCT TCT CAC TAT TTA GTC ATC CAA CTA TCA TGA GAA ACT CCT CCT TAT T
SP_0798 F3 AAA GGA GGA AAA TCA CAT GTC CAA CAC TTT GCG TAG TGT TGG GTA TC
SP_0798 R3 ATC ATC TCT CCG AGC TAA GTT CA
SP_1227 F1 AGT TCC ACA TCT AGG TGA CTG GTA G
SP_1227 R1 AAA GGA GGA AAA TCA CAT GTC CAA CCG CCG TGG TGT AGG GTA TTA CA
SP_1227 F3 CCT TCT CAC TAT TTA GTC ATC CAA CTT TCA TAT GTT CAC CTT TTT CTC TAC
SP_1227 R3 AGC CAT TTC CAG TAT TGC TTT TAA C
SP_1633 F1 TAG ATA GAT AAA GGC CAA GTC CAG A
SP_1633 R1 AAA GGA GGA AAA TCA CAT GTC CAA CAC CAA GAA AGG AAT AGG GTA CG
SP_1633 F3 CCT TCT CAC TAT TTA GTC ATC CAA CGT GCA TGC GCT TCT CCT TTT CC
SP_1633 R3 ATA ATG GAA CCT TGT GGA ATG AAT A
SP_2000 F1 GAG CGA ATT TTA TCT GTC AAG TGA T
SP_2000 R1 AAA GGA GGA AAA TCA CAT GTC CAA CAA TAT CGC GAA AGA ATC TGG TTG
SP_2000 F3 CCT TCT CAC TAT TTA GTC ATC CAA CTT TCA TCT ACT TTC TCT CT TAT AAA
SP_2000 R3 CTG GTT TTT CTT TTT CCT ATC CAA T
SP_2082 F1 GAT ATT TCT GCG ACT CAT TTT GAA C
SP_2082 R1 CCT TCTCAC TAT TTA GTC ATC CAA CTG TCA TCT ATT ATC TCC TAT TGG T
SP_2082 F3 AAA GGA GGA AAA TCA CAT GTC CAA CGG TTA TGG TTA TAA CTT CAA GGA G
SP_2082 R3 AGA TGC TCA ACA ATA TGC TCA AGA C
SP_2193 F1 CTA ATA AGT GGC TCA TCT GGT CAA T
SP_2193 R1 AAA GGA GGA AAA TCA CAT GTC CAA CGT GAA AAA TGT TGG GTA TAA GAT TAG
SP_2193 F3 CCT TCT CAC TAT TTA GTC ATC CAA CGT TCA TCT CTC TCC CTT TCT AC
SP_2193 R3 CAA GCT TCA GCT CTG AAA TTG TTA
SP_2235 F1 AAA TTG CTT TCC ATT CTT TAA ACT T
SP_2235 R1 AAA GGA GGA AAA TCA CAT GTC CAA CGA TAT TTT AGA GAA AAA ATC TCA AAA GT
SP_2235 F3 CCT TCT CAC TAT TTA GTC ATC CAA CAA CTT TCA TTC AAA TTC CCT CTT AAA
SP_2235 R3 GCC TAT TTT GAC AAG GAC TAC CTT T
SP_1678 F1 CTG GAA TGA CAC CTT CGT ATT TTT
SP_1678 R1_erm AA GGA GGA AAA TCA CAT GTC CAA CTT ACA AAG AAA AAT GAT GGA GGA G
SP_1678 F3_erm CCT TCT CAC TAT TTA GTC ATC CAA CGA ACA AAT CTA TTT TTT CTT TTG GAC
SP_1678 R3 GTA TCA AAG ACG AGG CAG TAG CAT
SP_1678 R1_km GTT TTA GTA CCT GGA GGG AAT AAT GTT ACA AAG AAA AAT GAT GGA GGA G
SP_1678 F3_km GCC ATT TAT TCC TCC TAG TTA GTC AGA ACA AAT CTA TTT TTT CTT TTG GAC
Erm_F GTT GGA TGA CTA AAT AGT GAG AAG GAG TGA TTA CAT GAA CAA
Erm_R GTT GGA CAT GTG ATT TTC CTC CTT TTT ATT TCC TCC CGT TAA ATA ATA G
12
Figure 1. Schematic of synthesis of DNA fragments for mutant construction by PCR
amplification and homologous recombination for integration of antibiotic resistance cassette into
chromosome of S. pneumoniae TIGR4.*
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Figure 1*
*Patel, Jenishkumar.  Environmental responses of two-component systems in Streptococcus sanguinis. 2010 Aug.
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Purification of PCR amplified fragments
PCR amplified DNA was purified using QIAGEN Sample and Assay
Technologies.  Essentially, 5 volumes Buffer PB (105l Buffer PB) was added to 21l
PCR sample and placed in a QIAquick spin column.  The column was placed in a 2ml
collection tube and centrifuged for 1 min.  The flow through was discarded.  To wash
away unbound DNA, 750l of buffer PE with ethanol was added to the column and
again centrifuged for 1 min.  The flow through was discarded and the column was
placed in a clean 2ml Eppendorf tube.  DNA was eluted with 20l of distilled water,
which sat at room temperature for 1 min, and then centrifuged for 1 min.  The
concentration of DNA fragments was measured using NanoDrop technology.
Fragments were combined in equivalent concentrations for ligation.
THY+HCl preparation
To prepare the THY+HCl media, 14.8g brain heart infusion (37g/1L BHI), 2g
yeast extract (0.5%), and 400l HCl (11M) was added to 400ml of distilled H2O and
mixed on a stir plate.  This solution was then autoclaved for 20 min, allowed to cool, and
kept for working stocks at 4C for weeks.
Agar plate preparation
To prepare agar plates, 14.8g brain heart infusion (37g/1L BHI) and 6g agar was
added to 400ml of distilled H2O and mixed on a stir plate.  This solution was autoclaved
for 20 min and cooled to 55C.  To make plates without antibiotic, we poured
approximately 10ml of this solution onto new Petri dishes, while working in the hood,
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and allowed plates to dry.  For antibiotic selection plates, we added and mixed
erythromycin to a final concentration of 10µg/ml or kanamycin to a final concentration of
500µl/ml into the autoclaved solution.   Approximately 10ml of this solution was poured
onto new Petri dishes and allowed to dry.  Plates were stored in -20C.
Transformation
Once all mutant DNA was synthesized, S. pneumoniae TIGR4 parent strain had
to be transformed into mutant strains for study.  The transformation protocol followed for
the TIGR4 strain was optimized from that outlined by A.L. Bricker et al. [10].  Mid-log
phase stock cultures were thawed and diluted 50-fold with media (20ul culture + 980ul
THY+HCl) in 14 separate conical tubes (one for each putative response regulator gene).
Tubes were incubated at 37°C under microaerophilic conditions for 3 hrs to reach
O/D600nm = 0.03, as read by a spectrophotometer.  To induce competency of cells, 10N
(1l) NaOH, 10% (10l) BSA, 1M (1l) CaCl2, and 2.8l CSP-2 (competence stimulating
peptide type 2) was added to each tube and incubated at a 37°C under microaerophilic
conditions for 14 min.  50ng of mutant donor DNA was then added to tubes and
incubated at 37°C under microaerophilic conditions for 90 min.  After 90 min, cells were
diluted 200-fold in media (5l cells + 995l THY+HCl).  Transformed mutant bacteria
were selected by spreading 100l of diluted cultures onto antibiotic (10mg/ml
erythromycin or 500mg/ml kanamycin) selection agar plates.  Plates were incubated at
37°C under microaerophilic conditions for 48 hrs.  Colonies were counted and
transformation efficiency was calculated using the formula: (CFU on plates with
antibiotic / CFU on plates with no antibiotic).
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Mutant confirmation and sequencing
To confirm mutant bacteria, a single colony from the antibiotic selection plate was
picked up using a Pipette tip and inoculated in 4ml of THY medium (without HCl) with
erythromycin (10g/ml) or kanamycin (500g/ml), depending on the antibiotic cassette
used to replace the target gene, and incubated at 37°C under microaerophilic
conditions, overnight until turbulence was observed.  Colony PCR was run using the
overnight culture and primers F1/R3 and reaction conditions of 94oC for 2 min., followed
by 30 cycles at 94oC for 30 s, 54 oC for 30 s, 68 oC for 3 min. 30 s, and finally 68 oC for
10 min.  Mutant bacterial cells were confirmed when bands were observed on 1% gel
electrophoresis.  Also, to further confirm correct mutants, DNA upstream of the antibiotic
cassette that is specific to all strains was sequenced by Virginia Commonwealth
University’s Nucleic Acids Research Facilities.  Sequence data was cross-referenced to
the TIGR4 genome database to confirm that the sequences matched for the correct
location of the target gene.  Mutant strains were stored in 30% glycerol in -80C.
In vitro studies
To elucidate growth rates of mutants, growth curves of each mutant, individually,
were constructed.  Each mutant strain from frozen stocks was inoculated in 5ml
THY+HCl and incubated at 37°C under microaerophilic conditions overnight.  Overnight
cultures were diluted 100-fold in media (56l culture + 5.54ml THY+HCl).  200l of each
mutant diluted culture was pipetted in triplicate in wells of 96-well PCR plates so that
each plate had repeats of every mutant.  One plate was made for every time point to be
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measured for the growth curve, therefore, eight plates were made for hourly time points
of 0, 4, 5, 6, 7, 8, 9, and 10.  Each plate was incubated in separate Anoxomat
(technology used to culture anaerobes and microaerobes) jars at 37°C under
microaerophilic conditions.  At each time point, a corresponding plate was removed
from incubation and the cell growth was measured using the FLUOstar plate reader
(BMG Technologies) at O/D600nm.  After 10 hrs of measurements, a growth curve using
the average of the hourly repeats for each mutant was constructed from the data
collected.
To examine how RR mutants grew when inoculated together, in vitro co-
inoculation was performed.  Frozen mid-log phase stocks of each mutant were thawed
and 100l was streaked out onto antibiotic selection plates.  Plates were incubated at
37°C under microaerophilic conditions for 48 hrs.  1-2 colonies from plates were
inoculated into tubes with 5ml BHI (brain-heart infusion). These tubes containing mutant
cells as well as one corresponding tube for each mutant of 12.6ml of BHI were
incubated at 37°C under microaerophilic conditions overnight.  Overnight mutant cell
cultures were confirmed to have an O/D660nm ~ 0.9.  1.4ml of each mutant culture was
transferred into the tube of 12.6ml pre-warmed BHI and quickly returned to incubate at
37°C under microaerophilic conditions for 3 hrs.  After 3 hrs, tubes were centrifuged at
4000 rpm for 10 min at 4C and supernatant discarded, twice.  Pellets were
resuspended and vortexed in 7ml cold sterile PBS.  The cell mixture was serially diluted
in PBS (400µl cells:400µl PBS; 300µl cells:500µl PBS; 100µl cells: 700µl PBS) and cell
growth was measured.  From serial dilution data, all mutant cell cultures were adjusted
to an O/D660nm = 0.8 (1x10^8 CFU) by adding PBS.  Finally, to combine all mutants in
18
culture to make what is referred to as the inoculum, 1ml of each mutant culture was
pulled together into one conical tube and vortexed.  100l of inoculum was transferred
into 10ml of BHI and incubated at 37°C under microaerophilic conditions overnight. The
in vitro inoculum was six times serially diluted by a 10-fold factor each time in PBS.
Also, 100l of each dilution was streaked onto antibiotic selection plates and incubated
at 37°C under microaerophilic conditions for 48 hrs, at which point a colony count was
made.  The remaining inoculum was centrifuged with the supernatant being discarded
and pellet stored in -80C.   Once the inoculum has been incubated overnight, it is now
the output.  The in vitro output was diluted and plated, just as the inoculum, to make a
colony count.  The bacterial colonies from inoculum and output plates of approximately
5,000 CFU (colony forming units) were isolated by adding 10ml of PBS and gently
scraping the surface of plates to detach colonies.  The liquid suspension was collected
in a conical tube and centrifuged to store the pellet and discard supernatant.  To isolate
DNA from bacterial pellets, the QIAamp DNA Mini and Blood Mini Kit (QIAGEN) for
purification of genomic DNA from gram-positive bacteria was followed. Pellets were
resuspended in 180l of an enzyme solution of 20mg/ml lysozyme, 1x Tris/EDTA (pH
8.0), and 1.2% Triton, incubated at 37°C for 30 min, and transferred to Eppendorf tubes.
20l Proteinase K and 200l Buffer AL was added to samples, mixed, and allowed to
incubate at 56°C for 1 hr with intervals of vortexing until the samples appeared clear in
color.  Tubes were briefly centrifuged before adding 200l Buffer AL, then mixed, and
incubated at 70°C for 10 min.  Samples were briefly centrifuged before adding 200l of
100% ethanol and mixed.  This mixture was applied to the QIAamp mini spin column
and centrifuged at 8000 rpm for 1 min.  The filtrate was discarded while the spin column
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was placed in a new collection tube.  500l Buffer AW1 was added and centrifuged.
The filtrate was discarded while the spin column was placed in a new collection tube.
To the spin column, 500l Buffer AW2 was added, centrifuged at 14,000 rpm for 3 min,
filtrate was discarded, and centrifuged again at 14,000 rpm for 1 min.  50l of distilled
water was added to the column, which was placed in a new collection tube, and allowed
to sit at room temperature for 5 min.  Finally, the tube was centrifuged at 8,000 rpm for 1
min and the flow through was kept as the mutant DNA samples.
These samples were diluted 10x to be used for real-time PCR (qPCR) as a way
of quantifying DNA of interest. Primers of approximately 25 bases for qPCR were
designed using Primer Express 3.0 software to amplify the specific sequence ligating
the erythromycin cassette and downstream fragment.  The forward primer was
complimentary to the erythromycin sequence, while the reverse primer was
complimentary to the specific sequence of the downstream fragment of each mutant.
The amount of target DNA was quantified based on a standard curved created by
serially diluting, by a 10-fold factor, a PCR amplified product of the gene of interest.
The PCR product, which the standard curve was based on, was of known DNA
concentration as determined by NanoDrop and adjusted to 0.5026ng/µl, which
corresponded to 2x105copies/µl.  We used 2µl of DNA as template, 1µl dH2O, 1µl of
each primer, and 5µl 2x PCR Master Mix (Applied Biosystems) in our qPCR reaction
mixture. Quantified DNA was applied in the competitive index formula: (mutant
output/control output) / (mutant input/control input), to analyze growth of each mutant
when co-inoculated.
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In vivo endocarditis model
To simultaneously screen all mutants for virulence effects in IE, rabbit models as
described in previous studies [11, 12] were used for in vivo infection and study.  To
induce endocarditis and valve damage, catheters were inserted into the internal carotid
artery, past the aortic valve of six anaesthetized rabbits.  Two days after catheterization,
the same inoculum prepared for in vitro studies (O/D660nm = 0.8 or 1x10^8 CFU, each
mutant) was loaded at 0.5ml volume into syringes for injection into the ear vein of
rabbits.  Twenty hours after injection, necropsy was performed.  Rabbits were sacrificed
by injection and their hearts were removed.  Tissue and vegetation were recovered,
grinded up, and homogenized.  In vivo output is referred to as the homogenate, which
after harvesting was vortexed, diluted and streaked onto selection plates in the same
manner as in vitro output. We performed colony counts from the in vivo homogenates
and inoculum and harvested the cells for qPCR.  A competitive index assay was done
just as for our in vitro samples.  Standard error and significance were calculated to
analyze growth of mutants in endocarditis models.
Once we had identified candidate virulent RRs, we confirmed our results by
performing an additional experiment in our animal IE model.  A second antibiotic
selection marker (Km) was used to replace the SP_1678 gene to form a control strain
[13].  We chose one candidate RR mutant, which resulted in a CI significantly less than
1, and mixed it with the control mutant in equal amounts (1x10^7 CFU).  This inoculum
was injected into the ear vein of three catheterized rabbit to evaluate the relative fitness
in IE.  Again, the bacteria was recovered from infected heart valves 20 hrs later, diluted,
and enumerated on selection plates with either Km or Erm [11].  Colonies that grew on
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Km plates were the control strain and colonies that grew on Erm plates were the
candidate RR mutant.  The colony counts were applied to the CI formula and
significance was calculated to confirm virulence of our candidates.
Statistical analysis
To calculate statistical significance of CI assays, we performed paired t-tests
comparing the CI results of each strain to 1, which is the value that would suggest the
response regulator has no affect in endocarditis virulence.  We used a cutoff p-value of
0.05 so that a p-value<0.05 suggested that CI results were significant.
Blood killing assay
To examine possible virulence mechanisms of candidate RRs, a CI assay was
performed using mutants in human blood.  All 13 RR mutants with Erm resistance, as
well as the control mutant SP_1678 with Km resistance were inoculated in 200l
THY+HCl media at 37C in microaerophilic conditions, overnight.  50l of overnight
cultures were transferred into 450l THY+HCl media in an autoclaved deep 96-well
plate and incubated at 37C in microaerophilic conditions for 4 hrs. After incubation,
cultures were at O/D660nm = 0.8 or 1x10^8 CFU, so that 0.5ml of control mutant could be
transferred into the wells containing RR mutant cells and mixed well by pipetting up and
down.  Cultures were then harvested by centrifuging at 4000 rpm for 10 min at 4C,
discarding supernatant, resuspending pellets in 1ml HBSS (Hank’s Buffered Salt
Solution), and repeating these steps once.  The bacterial mixture was serially diluted
(once by 100-fold and subsequently four times by 10-fold) in autoclaved deep 96-well
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plates and plated onto Erm and Km selection plates.  In addition, 10l of the remaining
bacterial mixture was added to 90l of human blood, which was collected no longer than
4 hrs prior to experimentation, in an autoclaved deep 96-well plate.  This plate was
incubated at 37C for 1 hr, while gently mixed.  Following incubation, the blood and
bacterial mixture was serially diluted (once by 100-fold and subsequently four times by
10-fold) and plated onto Erm and Km plates.  All plates were allowed to dry and
incubated at 37C in microaerophilic conditions for 2 days.  The colonies were
enumerated for CI calculations.
Literature and database search
We searched NCBI databases for papers and their GEO databases for
microarray data on gene expression, regulons, and disease models relating to
candidate virulence factors that we have identified in our experiments.
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RESULTS
Identification of TCS genes in S. pneumoniae TIGR4 strain
There were 46 streptococcal genomes completed as of April 2010, of which 11
were of S. pneumoniae strains.  From the databases of these genomes and use of
comparative genomics [14], we found all pneumococcal strains had either 13 or 14
TCSs.  In the TIGR4 strain, we identified 13 putative HKs and 14 putative RRs listed in
Table 3, including 1 orphan RR (SP_0376), which is in agreement with previous studies
and its homologous genes.  Also from our preliminary bioinformatic analysis, we
identified a gene, SP_1678, encoding a hypothetical protein that we used to synthesize
a mutant strain to be used at a control in subsequent experimentation.
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Table 3: A List of mutated genes used for study and their putative function
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Table 3
Gene      Putative Function TCS Possible Regulatory Function15
SP_0083 DNA-binding response regulator 08
SP_0156 DNA-binding response regulator 07
SP_0376 DNA-binding response regulator RitR orphan
SP_0387 DNA-binding response regulator 03
SP_0526 Response regulator BlpR 13 pheromone/peptide sensing
SP_0603 DNA-binding response regulator VncR 10
SP_0661 DNA-binding response regulator ZmpR 09 nutrient perception
SP_0798 DNA-binding response regulator CiaR  05 competence/penicillin susceptibility
SP_1227 DNA-binding response regulator  02 redox/energy sensing
SP_1633 DNA-binding response regulator 01
SP_2000 DNA-binding response regulator  11
SP_2082 Response regulator  04 phosphate sensing
SP_2193 DNA-binding response regulator  06
SP_2235 Response regulator ComE                12 quorum sensing/competence
SP_1678 Hypothetical protein
15 Lange R., Wagner C., Saizieu A., Flint N., Molnos J., Steiger M., Caspers P., kamber M., Keck W., Amrein K.E. Domain organization
and molecular characterization of 13 two-component systems identified by genome sequencing of Streptococcus pneumoniae. Gene. 1999 Sep;
237 (1): 223-234.
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Construction of mutants
To create mutants for genes of interest, we routinely use PCR associated site-
directed mutagenesis in our lab and we found this method to be useful in producing
consistent results for our S. pneumoniae experiments.  We used an antibiotic resistance
gene flanked by regions homologous to the chromosomal target gene as the cassette
for mutants.  An erythromycin-resistance cassette was used to synthesize all 14 RR
mutants, as well as SP_1678, which was our mutant control strain.  A kanamycin-
resistance cassette was also used to make a Km resistant SP_1678 mutant control
strain, which was used in later experiments so that RR mutants and control mutants
could be co-inoculated in vivo and selectively enumerated on different antibiotic plates
for competitive index assays. [13]. 1% gel electrophoresis confirmed that PCR
combined and amplified the three fragments (upstream, antibiotic-resistance cassette,
and downstream) for our final mutant DNA product to be used as donor DNA in
transformation.  Trials of PCR were repeated because not all mutants were successfully
amplified with the first attempt.  Also, oftentimes gels showed that the DNA synthesized
was impure because several other bands were observed in addition to the correct sized
band, so we repeated the PCR to get the cleanest results we could achieve.
Eventually, all RR mutant DNA of approximately ~3 kb were successfully made, as
displayed in Figure 2.
Confirmation of mutants by colony PCR and sequencing
After TIGR4 cells were transformed using our RR mutant DNA and cultured for
48 hrs on antibiotic selection agar plates, we found colonies grew for all of our mutants
27
except SP_1227.  We wanted to confirm that these bacterial colonies were indeed the
correct mutant cells with the antibiotic-resistance cassette replacing the gene of interest
in the genome.  To do so, we performed colony PCR on cells from the isolated colonies
using F1 and R3 primers for each mutant, respectively, as described previously.  The
correct sized band of approximately ~3 kb can be visualized on the 1% gel in Figure 3.
Another method we employed to confirm our mutants were correct was sequencing
DNA from mutant colonies by use of internal primers P1 (Figure 1).  The sequences of
60 bp obtained from our mutants are upstream of the target gene and can be seen in
Table 4 and matched the genomic database for TIGR4 RR genes.  Since all sequences
precisely matched, we were confident our mutants were correct and did not need to
further sequence downstream of the target gene.
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Figure 2. (A)1% agarose gel electrophoresis of PCR amplified products from the ligated
upstream, antibiotic resistance cassette, and downstream fragments. SP_0083 (lane 2),
SP_0156(lane 3), SP_0376 (lane 4), SP_0387 (lane 5), SP_0526 (lane 6), SP_0603 (lane 7),
SP_0661 (lane 8), SP_1227 (lane 9), SP_1633 (lane 10), SP_2000 (lane 11), SP_2082 (lane 12),
SP_2193 (lane 13), SP_2235 (lane 14), and 1kb DNA marker  (lane 1). Bands are shown in each
lane at ~3 kb, which confirms that all cassettes were successfully amplified except SP_0083,
SP_0798 and SP_2235, which are later amplified as shown in the second gel (B). SP_0083 was
synthesized in additional PCR reactions (data not shown).
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Figure 3. (A) 1% agarose gel electrophoresis of DNA fragments from colony PCR. ∆SP_0083
(lane 2), ∆SP_0156 (lane 3), ∆SP_0376 (lane 4), ∆SP_0387 (lane 5), ∆SP_0526 (lane 6),
∆SP_0603 (lane 7), ∆SP_0661 (lane 8), ∆SP_1227 (lane 9), ∆SP_1633 (lane 10), ∆SP_2000
(lane 11), ∆SP_2082 (lane 12), ∆SP_2193 (lane 13), ∆SP_2235 (lane 14), and 1kb DNA marker
(lane 1). Bands are shown in each lane at ~3 kb, which confirms that all TCS RRs replaced by
antibiotic-resistance cassettes into S. pneumoniae TIGR4 chromosome except ∆SP_0526,
∆SP_2082 and ∆SP_2193, which are later replaced as shown in the second gel (B)
31
Figure 3
(A)
(B)
SP
-00
83
SP
_01
56
SP
_03
76
SP
_03
87
SP
_05
26
SP
_06
03
SP
_06
61
SP
_07
98
SP
_16
33
SP
_20
00
SP
_20
82
SP
_21
93
SP
_22
35
SP
_21
93
SP
_20
82
SP
_05
26
32
Table 4. Sequence data upstream of target RR gene.  Sequencing performed by Virginia
Commonwealth University Nucleic Acids Research Facilities using internal erythromycin P1
primer designed by our lab.
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Table 4
Strain Upstream sequence and genome region
∆SP_0083 89041  CCATCTGTCTCTCCTTTGATAAAAACAGTGCTATACTGCTTTAAGTATAACACTATTTTT  88982
∆SP_0156 153585  ATACATTTTCTCCCTTTCTACTCATCTTGAATTGTAATACGATACTGAACACCGGCTTGC  153526
∆SP_0376 355164  CCCCATGGCTGACCTACTTATTTTTCGTCATACCAAGAGTAGTGGAAGGTTCCTTCTTTG  355105
∆SP_0387 366905  TTTCATCTTTACTCCTTTATCATTCCTTATCTAACAGGGGAATACGGATATCAACCGCCA  366846
∆SP_0526 505566  TCTCATCTTCTTACTCTCCCTCTTTCAACCATTTTTGACGAATTTCTCTATAGCGACGTC  505507
∆SP_0603 569487  TTTCATACTTTAACTGCTCTCTATTTTTTATTTTTCTTAGAATAAATACCTACCCTATTT  569428
∆SP_0661 631660  GGTCATGCTCTGCTCCTTTACCACTTACTAGTATCAGTATAGCAAAATTCTCCTCTAACT  631601
∆SP_0798 751967  TATCATGAGAAACTCCTCCTTATTAAAACTATTATACCAAATTTGCCTTAAAAAAAACTC  751908
∆SP_1633 1534188  TGCATGCGCTTCTCCTTTTCCATTATTATAACAGATTTTTCCATGCTAGATGGTCTGAAA  1534247
∆SP_1678 1578831  AAATCTATTTTTTCTTTTGGACTTTTTTCTATTTTTATCTATGGGCTTATAATCATATAC  1578890
∆SP_2000 1904343  TTTCATCTACTTTCTCTCCTTATAAAGTAGTCGAACCTGCACTTCAGTTGGATGTTTCTG  1904402
∆SP_2082 1991246  TGTCATCTATTATCTCCTATTGGTAACATTATAACACAATTATCAGAAATCCTAACATTG  1991187
∆SP_2193 2114758  AATGTTCATCTCTCTCCCTTTCTACTACCAGAACTCCATACATCTATTTCCTGTATGCTA  2114817
∆SP_2235 2156409  AACTTTCATTCAAATTCCCTCTTAAATCTAATGATTTGTCTAAATGTACTGCCTTCCATC  2156468
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Establishment of S. pneumoniae TIGR4 cell cultures
Once mutant DNA was synthesized, we tested various conditions to prepare
wild-type TIGR4 cells and to induce competence.  Competence is the ability of cells to
take up foreign DNA from the surrounding environment into their own genome.
Previous studies have reported low transformation efficiencies for the TIGR4 strain,
therefore, we optimized a protocol originally published by A.L. Bricker et al.  We first
needed to culture our stock cells to mid-log growth phase cells because it was reported
that cells in this phase are more competent.  We tested the incubation time required to
reach mig-log phase and whether the time was dependent upon source of stock cells.
Two sources of stock cells were tested, frozen cells taken directly from the -80°C and
cells from colonies that were streaked on TSA plates and incubated at 37°C for 48 hrs.
These two samples of TIGR4 cells were separately incubated in THY+HCl media at
37°C in microaerophilic conditions.  The cell growth was measured by a
spectrophotometer at 600nm at every 30 min for 8 hrs, at which point the stationary
phase of growth was reached. The growth curve is shown in Figure 4 and we found that
frozen cells incubated for 7-7.5 hrs grew best.  Growth media was another variable
tested to optimize efficiency. The original protocol reported using THY+HCl media to
culture cells, so we tested this media against TH+HS (Todd-Hewitt + horse serum)
media, which we regularly use in our lab to culture other streptococci.  Our results
confirmed THY+HCl is better for TIGR4 transformation because it yielded an efficiency
of 0.03%, while TH+HS media yielded 0.00% efficiency.  Lastly, we tested the oxygen
condition that was best for cell growth.  After 7 hrs of incubation, the optical density at
600nm of cultures were as follows aerobic = 0.22, microaerophilic = 0.55, and anaerobic
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= 0.61.  Cells did not grow sufficiently in aerobic conditions, while there was not a
significant difference between anaerobic and microaerophilic conditions.  We ultimately
grew cultures in microaerophilic conditions similar to the candle jars employed by
Bricker et al. and because it was more feasible, technically.  Finally, we settled on a
protocol that was most efficient and reproducible in our lab and resulted in an average
transformation efficiency of 0.02%, which was equivalent to that reported by Bricker et
al [10].  From colony PCR and sequencing data, all of our mutants were confirmed
except for RR SP_1227.  No colonies grew for the SP_1227 mutant and database
research showed that this gene is homologous to an essential gene, SSA_1565, of
Streptococcus sanguinis, therefore, we concluded that SP_1227 is essential in TIGR4.
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Figure 4: Growth curve of stock TIGR4 cells grown to mid-log phase.  Two sources of cells,
frozen stocks vs. colonies on TSA plates, were inoculated at in THY+HCl media at 37C in
microaerophilic conditions for 8 hrs.  Culture growth was measured using a photospectrometer at
600nm at 30 min intervals.
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Figure 4
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Examination of in vitro studies
As a preliminary step and reference for further study in our in vivo IE model, we
conducted in vitro experiments to elucidate growth rates of our mutants.  After
measuring growth of mutants inoculated individually, we found from the growth curve
shown in Figure 5 that all the RR mutants grew at similar rates to the control mutant,
SP_1678, except for RR SP_0798.  Data shows that SP_0798 grew slower than the
other 12 RR mutants.
We also wanted to examine growth rates of RR mutants when inoculated
together, as would be done when studied in our in vivo models.  To do so, we co-
inoculated mutant and quantified growth using specific primers and qPCR.  We
analyzed the data gathered from qPCR by calculating the competitive index for each
mutant.  A CI>1 suggests that the RR mutant grew faster than the control and a CI<1
suggests that the RR mutant grew slower than the control.  The CI values are shown in
Table 5 (B).  The majority of response regulator mutants had a CI>1, with the exception
of mutant strains SP_0376 and SP_2000, which had CI values less than 1.
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Figure 5: Growth curve of all 13 RR mutants with Erm-resistance cassettes, control mutant
∆SP_1678 with Erm- and Km-resistance cassette. Bacterial cultures were individually grown at
37°C in microaerophilic conditions over the course of 10 hrs.  Growth was measured by O/D
readings at 4 hrs and every hr thereafter on a FLUOstar plate reader at 600nm.  Mutant
∆SP_0798 showed significantly slower growth than all other mutants.
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Figure 5
In vitro Growth Curve
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Examination of in vivo studies
After our in vitro examination, we were prepared to screen mutants to observe
their role in virulence in an in vivo IE model.  To do so, we first co-inoculated all of our
RR mutants, including our control mutant into six rabbit IE models.  qPCR was
performed to quantify the behavior of mutants.  The data from qPCR, which are the
average of three repeats, along with the calculated CI and p-values can be seen in
Table 5.  From the CI information and statistics (cutoff p-value of 0.05), we saw that
SP_0156, SP_0376, SP_0603, SP_0661, SP_0798, SP_2082, and SP_2235 appeared
to have some role in virulence in endocarditis.  However, due to limitations on the
number of rabbit models we had available we could only choose one candidate RR to
further examine.
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Table 5. Real-time PCR and competitive index results
43
Table 5
A.  Quantitative real-time PCR results
strain inoculum in vitro output in vivo homogenate
∆SP_0083 3.14E+06 4.18E+07 1.36E+05
∆SP_0156 2.35E+06 1.20E+07 2.93E+05
∆SP_0376 5.91E+05 2.82E+03 undetected
∆SP_0387 6.94E+06 1.68E+08 1.27E+05
∆SP_0526 2.06E+07 5.09E+07 3.98E+05
∆SP_0603 1.58E+05 2.25E+06 1.83E+03
∆SP_0661 7.19E+05 6.97E+06 1.14E+04
∆SP_0798 9.73E+05 5.37E+06 undetected
∆SP_1633 1.09E+06 8.73E+06 1.83E+04
∆SP_2000 1.75E+05 1.82E+06 1.01E+04
∆SP_2082 2.56E+05 1.16E+06 1.46E+03
∆SP_2193 9.17E+05 4.55E+06 6.18E+04
∆SP_2235 1.60E+05 5.58E+05 1.84E+03
∆SP_1678 1.81E+06 2.57E+06 2.83E+04
B.  Competitive Index results and p-values
strain in vitro CI in vitro p-value in vivo CI in vivo p-value
∆SP_0083 9.4 0.0012 2.78 0.0122
∆SP_0156 3.59 0.0014 0.663 0.0129
∆SP_0376 0.003 0.0089 n/a n/a
∆SP_0387 17.07 0.0001 1.17 0.0866
∆SP_0526 1.74 0.0007 1.24 0.0006
∆SP_0603 10.87 0.0014 0.743 0.0513
∆SP_0661 6.78 0.0067 0.4 0.0132
∆SP_0798 3.88 0.0011 n/a n/a
∆SP_1633 5.67 0.0035 1.07 0.3388
∆SP_2000 0.732 0.0036 0.366 0.1712
∆SP_2082 3.21 0.0016 0.367 0.0289
∆SP_2193 3.47 0.0029 4.28 0.0084
∆SP_2235 2.41 0.024 0.723 0.013
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Examination of CiaR mutant in endocarditis virulence
Based on previous literature and putative functions as well as our in vivo CI
results from co-inoculation, we chose to test candidate RR SP_0798, also known as
gene ciaR. This mutant strain showed significant decreased growth in rabbit
endocarditis models, which suggests that its response regulator gene played an
important role in virulence, so we wanted to further examine it. The results of our
candidate RR mutant and the control mutant inoculation in rabbit IE models, as well as
the CI numbers and P-values are shown in Figure 6.
Blood killing assay
The results of our blood killing assay were inconclusive.  Although our control
mutant grew successfully on kanamycin selection plates before and after inoculation in
human blood, our RR mutants did not have consistent growth on erythromycin selection
plates. ∆SP_0083 and ∆SP_0661 displayed consistent growth on input and output
selection plates, but the remaining 11 RR mutants did not grow on plates at all (data not
shown).
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Figure 6. In-vivo competitive index experiment with candidate virulence factor RR ∆SP_0798
and control ∆SP_1678.  (A) Graph displays log value CFU per 100ul spread onto selection
plates. Output CFU shown is average of three repeats. Error bars are the distribution of the
repeats from the average. (B) CI was calculated for the three repeats of in vivo homogenate.  The
average CI as well as the P-value is also shown.
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Figure 6
(A)
(B)
Sample ∆SP_0798 CI P-value
in vitro output 0.18
in vivo homogenate-568 0.07
in vivo homogenate-569 0.08
in vivo homogenate-570 0.12
 avg in vivo homogenate 0.09 0.000282
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DISCUSSION
Streptococcus pneumoniae is a gram-positive, alpha-hemolytic bacterium that is
native in the upper respiratory tract of humans.  It has been subject to much scrutiny
due its prevalent role in many diseases such as pneumonia, bacteremia, otitis media,
meningitis, sinusitis, peritonitis and arthritis.  However, its role in infective endocarditis is
less studied because it is not a common cause of the disease. Although the cause of IE
is mostly attributed to viridans streptococci, it has been reported that S. pneumoniae is
the cause of 1-3% of adult cases of IE [16] and 3-5% in children [17].  It is notable that
pneumococcal endocarditis in association with diseases such as meningitis and
pneumonia is unique to Austrian Syndrome, which is a highly aggressive and often fatal
condition [5]. When the pneumococcal pathogen accesses the bloodstream, it can
infect the heart valves and complicate IE.
Although researchers have found that the encapsulated isolates are up to 105
more virulent in invasive diseases, than those that are nonencapsulated [18], it is
unclear what specific genes of S. pneumoniae cause it to facilitate IE, so we set out to
study these virulence factors.  The chemical structure and thickness of the capsule is
related to the ability of the bacteria to survive in the blood of hosts.  There have been 90
different serotypes [18] of S. pneumoniae identified based on the presence and
composition of the polysaccharide capsule. Our study focuses on the highly virulent
encapsulated TIGR4 strain known as S. pneumoniae serotype 4.   Research on TIGR4
is more tedious in comparison to the avirulent, nonencapsulated R6 strain because a
correlating characteristic of a polysaccharide capsule is that the bacteria are much more
difficult to transform into mutants for study.  Specifically, the R6 strain has a
48
transformation efficiency of ~1%, while the TIGR4 strain has an efficiency of only 0.02%
[10].  Other notable differences between the strains that may contribute to virulence
relate to amino acid biosynthesis, cellular processes and envelope, central metabolism,
and signal transduction [18].  Genes involved in signal transduction through two-
component systems (TCSs) have been characterized as virulence factors in disease
models such as pneumonia and meningitis in various studies [9], but no studies have
included IE.  TCSs are composed of a histidine kinase (HK) protein that senses the
environment and a corresponding response regulator (RR) that regulates gene
transcription for the bacterium to appropriately adapt, thrive, and in the case of disease,
escape host defenses.  The whole genome of TIGR4 has been sequenced and has
2,160,837 base pairs with 2236 coding regions, of which 1440 have putative biological
functions [19].  There are 14 RRs and 13 HKs, including an orphan regulator, identified
in S. pneumoniae TIGR4.
The primary goal of this study was to place more research emphasis on
strategies to combat pneumococcal bacteria in IE by analyzing the role of RRs and their
regulons in virulence of S. pneumoniae TIGR4 strain. Although there are presently two
commonly administered vaccines against S. pneumoniae, they are aimed towards
disease models such as pneumonia and meningitis, not endocarditis.  It would be better
if we could identify virulence factors in IE for vaccine design against this disease model.
Also, the current vaccines target surface proteins that are specific to a limited number of
serotypes.  Since we are examining virulence roles intracellular signaling transduction
proteins and target genes that are common in S. pneumoniae, development of a
vaccine aimed at these proteins may provide pleiotropic protection.
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We established a system of synthesizing 14 RR mutant strains by replacing
target genes with an antibiotic-resistance cassette using PCR amplification and
integrating this DNA into the genome by homologous recombination.  We found one RR
gene SP_1227, which is part of TCS02, to be essential in that mutants were not viable.
Behavior of all other mutants was tested by mixing and inoculating them in both in vitro
and in vivo rabbit endocarditis models.  Virulence was assessed by the growth rates of
mutants as measured by quantitative real-time PCR and competitive index assays.  We
found several mutants with decreased growth in the rabbits, but picked one candidate
virulence factor in SP_0798 and further tested it, individually, in rabbit endocarditis
models.  Mutant SP_0798 was confirmed to have significantly reduced growth based on
its CI.  We searched literature and databases to elucidate the regulon of this regulator
and found that it had many functions.
Of the 11 S. pneumoniae completed genomes, all contained either 13 or 14
TCSs.  To synthesize our 14 TIGR4 RR mutants, we optimized the protocol outlined by
Bricker et al.  TIGR4 cells undergo cycles of competency and refractory, therefore, they
must be cultured for 7-7.5 hrs to mid-log phase when they are most competent.  The
THY+HCl media used to culture bacteria was ideal because the acid slows entry into
competency so that natural competency and addition of endogenous CSP do not
overcompensate each other and reduce efficiency.  The glycine supplemented in media
partially disrupts the cells wall to facilitate CSP and exogenous DNA entry for
transformation.  After transformation, we confirmed what was reported in previous
papers [9], by background database searches, and experiments performed in our lab by
Jenishkumar Patel that SP_1227 is homologous to SSA_1565 in S. sanguinis and yycG
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in B. subtilis. These genes are essential in their respective organisms.  SP_1227
mutants formed no viable colonies and led us to believe that this TCS regulates genes
that are required for S. pneumoniae viability.  RR SP_0526 was once thought to be
essential because no colonies appeared to grow in mutants, however, it was later
shown that this mutant has a very low transformation efficiency [15].  Using our
optimized transformation protocol, it was still difficult to synthesize mutant SP_0526.
Our colony PCR results, as seen in Figure 3, show that it took repeated trials for mutant
colonies to finally grow and collected.  All other TCS RR formed several apparent
colonies and were successfully transformed.
In previous studies with regards to diseases such as pneumonia and
bacteraemia, TCS01, TCS02, TCS04, TCS05, TCS06, TCS07, TCS08, TCS09, TCS12,
TCS13, and TCS14 were found to have some role in virulence [9].  TCS14 is composed
of an orphan RR without a correlating HK and is identified as SP_0376 in TIGR4.  The
virulence of TCS14 appears to be tissue specific and due to the fact that it regulates
iron transport [20].  Iron is essential for bacterial growth, however, it can be detrimental
at high levels in certain tissue when it is converted to reactive oxygen species from
hydrogen peroxide.  TCS09 consisting of RR SP_0661 in TIGR4 has been
demonstrated to have a major role in virulence in pneumonia and bacteraemia,
however, the extent of its virulence is dependent on strain and site of infection [9].
Similarly, TCS04 consisting of RR SP_2082 in TIGR4 is a virulence factor in pneumonia
that is strain specific and reported to show the most virulence in the TIGR4 strain.   As a
virulence factor, TCS04 regulates the psa operon, which contributes to resistance to
oxidative stress [21].  Resistance to oxidative stress can be beneficial to bacterial
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survival against host immune defenses that employ reactive oxygen species (ROS) to
kill pathogens. TCS12 encodes HK comD and RR comE, which are responsible for the
natural competency of S. pneumoniae, however, this TCS has also been linked to
virulence in pneumonia and bacteraemia [22]. In addition to regulating competency
genes, TCS12 also regulates virulence factors autolysin LytA, stress response protein
HtrA, and choline binding protein CbpD.  TCS13 consisting of RR SP_0526 in TIGR4 is
a virulence factor that regulates synthesis and export of bacteriocin-like peptides, which
are predicted to kill competing microbes and/or have a cytotoxic effect on hosts,
allowing a growth advantage in its environment [23].
From our in vitro growth curve we found that most of our response regulator
mutants grew at comparable rates to our control strain, with the exception of the
SP_0798 mutants, which grew slower.  However, for our in vitro competitive index
assay, we observed that most mutants, including the SP_0798 strain, had a CI
significantly greater than 1, which indicated that the mutants grew more than the control
strain.  In the case of SP_0798, we hypothesize that the other mutants were
compensating for the missing function of ∆SP_0798, and therefore, allowed it to grow at
faster rates than what was observe when we performed the individual growth curve.
Also, it is possible that the increased growth of the other response regulator mutants
when compared to the control is because the response regulator mutants were slower
to reach their stationary growth phase than the control, and that this was just not
observed in the span of the growth curve experiment.  In the cases where mutants had
a CI<1 as seen with strains SP_0376 and SP_2000, which indicated they grew slower
than the control strain.  This result contrasts the growth patterns observed in the growth
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curve of individual strains, and we suppose that may be because when strains were co-
inoculated they were competing and some factors inhibited the growth of strains
SP_0376 and SP_2000.
For study on endocarditis virulence, we co-inoculated all 13 TIGR4 RR mutants
along with 1 control mutant in rabbit models.  DNA was isolated from vegetation formed
on heart valves of rabbits.    Growth of RR mutants was compared to growth of the
control mutant, which behaved analogously to wild type, by real-time PCR (qPCR) with
specific primers and competitive index assays.  CI<1 suggested that a mutant had
reduced virulence in IE, therefore, the RR was a possible virulence factor.  Based on
our model, we found SP_0156/TCS07, SP_0376/TCS14, SP_0603/TCS10,
SP_0661/TCS09, SP_0798/TCS05, SP_2082/TCS04, and SP_2235/12 were possible
virulence factors.  Of these, SP_0603/TCS10 was of particular surprise because it had
not been reported as having a role in virulence in previous studies of other diseases.  It
was reported that TCS10, also annotated as vncRS, had some role on vancomycin
tolerance [24] but its biological functions are still to be determined.  The study did
perform microarray analysis of SP_0603 (data not shown), which revealed that mutants
had more than two-fold upregulation of a ribosomal protein L31 and three cell wall
anchor proteins (SP_0462-SP_0464) as well as down-regulation of purine metabolism
genes, pbuX and purK. The significance of these gene functions in virulence has yet to
be determined.
Due to time limitations and availability of rabbit models, we were only able to
select one candidate virulence factor for further examination.  Based on the CI assay,
we chose SP_0798 because the mutant showed significantly decreased growth in IE
53
models and previous literature on its functions led us to believe it may be a virulence
factor.   We individually inoculated ∆SP_0798 with our control mutant and confirmed
that it did indeed have a role in virulence.  From these results we searched microarray
databases and literature relating to the regulon and function of SP_0798, which is also
known as the ciaR gene.  It appears the ciaR regulates many target genes with findings
that its gene product binds various promoter sites.  Microarray data also identified
several genes that were significantly upregulated or downregulated by the mutant in
comparison to the wild type.  General features of target genes include sugar
metabolism, competence, stress response, autolysis, and virulence. Table 6 was put
together by Mascher et al. [26] and summarizes the genes they identified as part of the
ciaR regulon.  We observed that SP_0798 had diverse functions including those in
competence, antibiotic (beta lactam) resistance, stress responses, autolysis,
polysaccharide metabolism and transport, and virulence.  Several genes were
transcribed from promoters regulated by ciaR including those for modification of teichoic
acids (lic), sugar metabolism and transport (mal, man), temperature stress response
(htrA), chromosome segregation (parB), and protease maturation (ppmA). Regulation
of sugar metabolism and transport is likely to have a role in virulence as it would
contribute to cell wall and capsule synthesis and composition.  The cell wall and capsule
protects the entire cell, as discussed earlier, and therefore is important for its ability to
survive any environment.  Also, it is reported that in S. pneumoniae the htrA or high-
temperature requirement A gene, also known as DegP/DO protease, confers tolerance
to temperature shifts that pathogens often encounter.  HtrA is a serine protease that can
act as a molecular chaperone and have proteolytic activity, which usually serve for
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quality control of other proteins in situations of high temperatures.  In addition to heat
resistance, HtrA can prevent protein degradation and assist in protein folding in
situations of oxidative and osmotic stress [25].  The ability of HtrA to aid the cell in
response to the environment through the TCS RR SP_0798 signaling may explain its
role in virulence. Interestingly, five strongly regulated promoters by ciaR were for the
expression of small non-coding RNAs, otherwise known as cia-dependent small RNAs
or csRNAs.  It was reported that csRNA4 and csRNA5 affected stationary phase
autolysis [26].  Another study reported that the ciaR target site affected biological
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Table 6.  Putative target genes of ciaR from Mascher et al [26]
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Table 6
Region Gene(s)a TIGR4 annotation
1 Hypothetical; ugd* SP0133-SP0137
2 gpmB*, pflE*, deoR* SP0239-SP0247
3 ruvB*, uppS SP0256-SP0262
4 manLMN* SP0281-SP0285
5 spiAB, pnc (blp) cluster SP0524-SP0533
6 fibB (murN) SP0611-SP0617
7 deoAC* SP0839-SP0845
8 pit2ABCD SP1030-SP1037
9 Hypothetical SP1057-SP1067
10 orf2 and -3, licABC SP1266-SP1274
11 pgm*, bta* SP1694-SP1499
12 axe* SP1694-SP1697
13 sacA Downstream of SP1795
14 cyl SP1945-SP1954
15 Hypothetical; 23S RNA SP2001-SP2005
16 malPM SP2104-SP2108
17 dltABCD* SP2173-SP2178
18 orfL, htrA*, spo0J* SP2234-SP2240
*homologs
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peptide production including bacteriocin and cytolysin [27]. Bacteriocins are protein
toxins and their secretion from one strain of bacteria can kill competing microbes or
damage host defenses so it may be advantageous for S. pneumoniae in hosts and a
way to complicate IE.  Cytolysins are proteins secreted by bacteria that cause the death
of other cells such as red blood cells by lysis, and therefore, their role in virulence may
be similar to bacteriocins, as mentioned previously, in that they provide bacteria a
growth advantage by inhibiting host defenses.
It is of interest to uncover the pathways and their correlated phenotypes
regulated by the ciaR gene and other virulence factors against hosts to determine better
methods to combat bacteria.  A study focused on Group B Streptococci (GBS) reported
that ciaR mutants had significant decreases in intracellular survival in neutrophils,
macrophages, and human brain microvascular endothelial cells. These mutants showed
less viability because they were more susceptible to killing by antimicrobial peptide,
lysozymes, and reactive oxygen species of the immune system [28].  Although this
study is on a different organism than our study, we can turn on our attention to the
possibility that S. pneumoniae may use similar mechanisms in hosts.  We can study
these mechanisms by performing blood killing assay and phagocytosis assays. Our
blood killing assay produced inconclusive results and needs to be repeated.  We
hypothesize that the erythromycin concentrations used for selection plates were too
high and killed most bacterial strains that were sensitive and that ∆SP_0083 and
∆SP_0661 strains were able to grow because they had higher expression of the
erythromycin cassette and tolerated the antibiotic.  A phagocytosis assay was
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performed by our lab member Jenishkumar Patel with the protocol routinely used for
Streptococcus sanguinis, which is commonly studied in our lab.  This assay is an in vitro
experiment to test how RR mutants behaved in the presence of macrophage cells,
which are cells part of the immune system that kill pathogens.  We hypothesized that
mutant strains that had a role in virulence reduced colonies numbers in comparison to
the control strain because deletion mutants were susceptible to macrophage killing.
However, we were not able to confirm or deny our hypothesis because mutants did not
grow consistently and results were not reliable.  We believe this we because the growth
rate of S. pneumoniae is much slower than that of S. sanguinis, therefore, the protocol
must be adjusted to account for this difference for better results.
Much of our results are preliminary and further experimentation needs to be
performed for more definite conclusions.  Our inoculation of RR mutant strains in
endocarditis rabbit models for in vivo study needs to be repeated so that results can be
proven to be reproducible.  We also need more rabbit endocarditis models to
individually test the other TCS RRs (SP_0156/TCS07, SP_0376, SP_0603/TCS10,
SP_0661/TCS09, SP_0798/TCS05, SP_2082/TCS04, and SP_2235/12) that we
identified as candidate virulence factors.  In addition to repeating our experiments,
future experiments for analysis on the regulons of TCS RRs that are virulence factors
may be performed.  Chromatin immunoprecipitation (ChIP) and sequencing can identify
DNA-binding sites of candidate TCS RRs and reveal what genes are being regulated by
the protein.  Once putative binding sites have been identified, a method to examine
protein-DNA binding affinity would be by way of an Electrophoretic Mobility Shift Assay
(EMSA).  In the EMSA, competing probes with known sequences along with a
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radioactive labeled probe of interest would be incubated with the candidate TCS RR
protein.  These experiments may elucidate the regulons of RRs, and therefore, by
identifying the gene functions and the pathways they are involved in we can understand
their contribution to virulence.
In conclusion, this study is a preliminary step in demonstrating that a number of
TCS RRs in S. pneumoniae TIGR4 strain have some role in virulence in infective
endocarditis.  Further experiments may confirm our candidate response regulator
SP_0798, as well as other candidates, as virulence factors so that they themselves or
genes within their regulon could potentially be vaccine candidates for IE.  Therefore,
identification of regulatory networks of these TCSs may reveal novel signaling pathways
related to IE and lead to better preventative methods against the disease.    Altogether,
results will hopefully bring more attention to S. pneumoniae as a causative agent for IE
and lead to more research on the subject.
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